Eigen Therapeutics

Making therapies to make cancer easier to find and eliminate.

About

Founded

2019

Headquarters

Redwood City, California

Industry

Biotech

Company Description

Eigen Therapeutics is a biotechnology company on a mission to make therapies that make cancer easier to find and eliminate. Eigen is focused on the development of “priming” therapies, therapies that help targeted therapies reach their full potential by addressing cancer heterogeneity, making cancer cells more vulnerable and/or making healthy cells more resilient to treatment.

Quick Links

WebsiteJobs

Funding

Total Raised

$7 million

Valuation

Undisclosed

Significant Investors

First Round Capital, Hawktail, Bioverge, SNR, Builders VC, Alumni Ventures, Mount Pleasant Ventures

Company Traction

  • Eigen Therapeutics emerged from stealth in December 2022.

Leadership Team

  • Transon Nguyen: Co-Founder & CEO of Eigen Therapeutics. Former VP of Engineering at Notable.
  • Kamran Ali: Co-Founder & CTO of Eigen Therapeutics. Former Head of Platform and Discovery at Notable.
  • Kathryn Vanderlaag: Chief Scientific Officer at Eigen Therapeutics. Former VP of Research & Development at Notable.

Press

People also viewed